Search

Daniel P. Shook

Examiner (ID: 18974)

Most Active Art Unit
2898
Art Unit(s)
2823, 4116, 2896, 2898
Total Applications
1165
Issued Applications
1020
Pending Applications
77
Abandoned Applications
93

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19403605 [patent_doc_number] => 20240287116 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-29 [patent_title] => SEPARATION OF HUMAN MILK OLIGOSACCHARIDES FROM A FERMENTATION BROTH [patent_app_type] => utility [patent_app_number] => 18/570021 [patent_app_country] => US [patent_app_date] => 2022-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12633 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18570021 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/570021
SEPARATION OF HUMAN MILK OLIGOSACCHARIDES FROM A FERMENTATION BROTH Jun 13, 2022 Pending
Array ( [id] => 18285755 [patent_doc_number] => 20230101227 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-30 [patent_title] => COMPOSITIONS COMPRISING REVERSIBLY MODIFIED OLIGONUCLEOTIDES AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/836209 [patent_app_country] => US [patent_app_date] => 2022-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35609 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17836209 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/836209
Compositions comprising reversibly modified oligonucleotides and uses thereof Jun 8, 2022 Issued
Array ( [id] => 18108009 [patent_doc_number] => 20230000889 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-05 [patent_title] => METHODS OF TREATING ACUTE MYELOID LEUKEMIA AND MANAGING CYTOPENIA [patent_app_type] => utility [patent_app_number] => 17/834642 [patent_app_country] => US [patent_app_date] => 2022-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17627 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17834642 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/834642
METHODS OF TREATING ACUTE MYELOID LEUKEMIA AND MANAGING CYTOPENIA Jun 6, 2022 Abandoned
Array ( [id] => 18101202 [patent_doc_number] => 11541071 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2023-01-03 [patent_title] => Nucleoside derivatives and methods of use thereof [patent_app_type] => utility [patent_app_number] => 17/664304 [patent_app_country] => US [patent_app_date] => 2022-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38213 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17664304 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/664304
Nucleoside derivatives and methods of use thereof May 19, 2022 Issued
Array ( [id] => 19331288 [patent_doc_number] => 20240245718 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-25 [patent_title] => MEDIUM MOLECULAR WEIGHT HEPARIN FOR USE IN THE TREATMENT OF ENDOTHELIOPATHY [patent_app_type] => utility [patent_app_number] => 18/290533 [patent_app_country] => US [patent_app_date] => 2022-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18154 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -30 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18290533 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/290533
MEDIUM MOLECULAR WEIGHT HEPARIN FOR USE IN THE TREATMENT OF ENDOTHELIOPATHY May 15, 2022 Pending
Array ( [id] => 18647796 [patent_doc_number] => 20230293569 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-21 [patent_title] => MODULATING NUDIX HOMOLOGY DOMAIN (NHD) WITH NICOTINAMIDE MONONUCLEOTIDE ANALOGS AND DERIVATIVES OF SAME [patent_app_type] => utility [patent_app_number] => 17/737541 [patent_app_country] => US [patent_app_date] => 2022-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41947 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17737541 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/737541
Modulating Nudix homology domain (NHD) with nicotinamide mononucleotide analogs and derivatives of same May 4, 2022 Issued
Array ( [id] => 19165811 [patent_doc_number] => 11981698 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-05-14 [patent_title] => Methods of preparing reduced nicotinamide riboside and derivatives thereof [patent_app_type] => utility [patent_app_number] => 17/736834 [patent_app_country] => US [patent_app_date] => 2022-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8002 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 184 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17736834 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/736834
Methods of preparing reduced nicotinamide riboside and derivatives thereof May 3, 2022 Issued
Array ( [id] => 17911324 [patent_doc_number] => 20220313719 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-06 [patent_title] => METHODS OF TREATING DISEASES ASSOCIATED WITH CHANGES IN PLATELET COUNTS USING PROTEIN KINASE A ACTIVATOR AND INHIBITOR [patent_app_type] => utility [patent_app_number] => 17/728895 [patent_app_country] => US [patent_app_date] => 2022-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8682 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17728895 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/728895
METHODS OF TREATING DISEASES ASSOCIATED WITH CHANGES IN PLATELET COUNTS USING PROTEIN KINASE A ACTIVATOR AND INHIBITOR Apr 24, 2022 Abandoned
Array ( [id] => 18245953 [patent_doc_number] => 11602516 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2023-03-14 [patent_title] => Treating benign prostatic hyperplasia [patent_app_type] => utility [patent_app_number] => 17/727675 [patent_app_country] => US [patent_app_date] => 2022-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 12 [patent_no_of_words] => 21885 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17727675 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/727675
Treating benign prostatic hyperplasia Apr 21, 2022 Issued
Array ( [id] => 19246778 [patent_doc_number] => 20240197762 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-20 [patent_title] => NUTRITIONAL COMPOSITION FOR STIMULATIONG BIFIDOBACTERIA [patent_app_type] => utility [patent_app_number] => 18/286505 [patent_app_country] => US [patent_app_date] => 2022-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3544 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18286505 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/286505
NUTRITIONAL COMPOSITION FOR STIMULATIONG BIFIDOBACTERIA Apr 11, 2022 Pending
Array ( [id] => 19889077 [patent_doc_number] => 20250114389 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-04-10 [patent_title] => NUCLEOSIDES AND NUCLEOTIDES ANALOGS AS ANTIVIRAL AGENTS [patent_app_type] => utility [patent_app_number] => 18/285778 [patent_app_country] => US [patent_app_date] => 2022-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33826 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18285778 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/285778
NUCLEOSIDES AND NUCLEOTIDES ANALOGS AS ANTIVIRAL AGENTS Apr 10, 2022 Pending
Array ( [id] => 19586383 [patent_doc_number] => 20240383940 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-21 [patent_title] => SYNTHESIS OF TRINUCLEOTIDE AND TETRANUCLEOTIDE CAPS FOR MRNA PRODUCTION [patent_app_type] => utility [patent_app_number] => 18/284395 [patent_app_country] => US [patent_app_date] => 2022-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21676 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -66 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18284395 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/284395
SYNTHESIS OF TRINUCLEOTIDE AND TETRANUCLEOTIDE CAPS FOR MRNA PRODUCTION Mar 29, 2022 Pending
Array ( [id] => 19265319 [patent_doc_number] => 20240209018 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-27 [patent_title] => UNIVERSAL LINKER REAGENTS FOR DNA SYNTHESIS [patent_app_type] => utility [patent_app_number] => 18/551834 [patent_app_country] => US [patent_app_date] => 2022-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11365 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18551834 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/551834
UNIVERSAL LINKER REAGENTS FOR DNA SYNTHESIS Mar 21, 2022 Pending
Array ( [id] => 18994591 [patent_doc_number] => 11911408 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-02-27 [patent_title] => Synergistic formulations of adenosine receptor modulating agents and anticholinergics [patent_app_type] => utility [patent_app_number] => 17/692383 [patent_app_country] => US [patent_app_date] => 2022-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 13256 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17692383 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/692383
Synergistic formulations of adenosine receptor modulating agents and anticholinergics Mar 10, 2022 Issued
Array ( [id] => 18930973 [patent_doc_number] => 11883367 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-01-30 [patent_title] => 6-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inhibitors [patent_app_type] => utility [patent_app_number] => 17/690587 [patent_app_country] => US [patent_app_date] => 2022-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 69496 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 664 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17690587 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/690587
6-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inhibitors Mar 8, 2022 Issued
Array ( [id] => 19139649 [patent_doc_number] => 20240138410 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-02 [patent_title] => AGRICULTURAL COMPOSITION COMPRISING KASUGAMYCIN [patent_app_type] => utility [patent_app_number] => 18/548110 [patent_app_country] => US [patent_app_date] => 2022-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9045 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18548110 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/548110
AGRICULTURAL COMPOSITION COMPRISING KASUGAMYCIN Feb 27, 2022 Pending
Array ( [id] => 17837714 [patent_doc_number] => 20220275019 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-01 [patent_title] => HYDROCINNAMOYL PROTECTED RIBOGUANOSINE PHOSPHORAMIDITES FOR DECREASING DEPYRIMIDINATION FROM ALKYL AMINE EXPOSURE DURING FINAL DEPROTECTION [patent_app_type] => utility [patent_app_number] => 17/681731 [patent_app_country] => US [patent_app_date] => 2022-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13047 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17681731 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/681731
HYDROCINNAMOYL PROTECTED RIBOGUANOSINE PHOSPHORAMIDITES FOR DECREASING DEPYRIMIDINATION FROM ALKYL AMINE EXPOSURE DURING FINAL DEPROTECTION Feb 25, 2022 Pending
Array ( [id] => 18871146 [patent_doc_number] => 11858931 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-01-02 [patent_title] => Amino acid compounds with unbranched linkers and methods of use [patent_app_type] => utility [patent_app_number] => 17/679002 [patent_app_country] => US [patent_app_date] => 2022-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 2 [patent_no_of_words] => 32445 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17679002 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/679002
Amino acid compounds with unbranched linkers and methods of use Feb 22, 2022 Issued
Array ( [id] => 19280105 [patent_doc_number] => 20240216578 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-04 [patent_title] => COMPOSITE ULTRATHIN COATING FILM WITH INHIBITORY ACTIVITY AGAINST HYPERINFLAMMATORY RESPONSE AND BACTERIA, IMPLANT INCLUDING SAME, AND PREPARATION METHOD THEREFOR [patent_app_type] => utility [patent_app_number] => 18/569988 [patent_app_country] => US [patent_app_date] => 2022-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5362 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 170 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18569988 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/569988
Composite ultrathin coating film with inhibitory activity against hyperinflammatory response and bacteria, implant including same, and preparation method therefor Feb 13, 2022 Issued
Array ( [id] => 20343127 [patent_doc_number] => 12466849 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-11-11 [patent_title] => Anti-viral and anti-tumoral compounds [patent_app_type] => utility [patent_app_number] => 17/583378 [patent_app_country] => US [patent_app_date] => 2022-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 76 [patent_figures_cnt] => 105 [patent_no_of_words] => 65301 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17583378 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/583378
Anti-viral and anti-tumoral compounds Jan 24, 2022 Issued
Menu